Quick Answer
Progyny, Inc. reported Operating Income Loss of $85.28 million for the year ending 2025.
- Progyny, Inc. showed an increase of +26.4% in Operating Income Loss from 2024 to 2025.
- This data is from Progyny, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$1.85 million | Q2 2018: -$317.0 thousand | Q3 2018: -$587.0 thousand | Q4 2018: -$703.0 thousand | Q1 2019: $3.11 million | Q2 2019: $2.35 million | Q3 2019: $3.07 million | Q4 2019: $1.14 million | Q1 2020: $3.43 million | Q2 2020: -$1.07 million | Q3 2020: $4.83 million | Q4 2020: $1.16 million | Q1 2021: $11.81 million | Q2 2021: $11.66 million | Q3 2021: $9.07 million | Q4 2021: -$188.0 thousand | Q1 2022: -$58.0 thousand | Q2 2022: $8.84 million | Q3 2022: $11.26 million | Q4 2022: $3.31 million | Q1 2023: $15.01 million | Q2 2023: $15.18 million | Q3 2023: $18.19 million | Q4 2023: $13.80 million | Q1 2024: $18.52 million | Q2 2024: $20.69 million | Q3 2024: $12.46 million | Q4 2024: $15.79 million | Q1 2025: $24.17 million | Q2 2025: $24.36 million | Q3 2025: $21.53 million | Q4 2025: $15.22 million.
- Over the full 9 years of available data (2017 to 2025), Progyny, Inc.'s Operating Income Loss has grown by 874.9%.
- Historical annual values: Fiscal year 2025: $85.28 million | Fiscal year 2024: $67.46 million | Fiscal year 2023: $62.18 million | Fiscal year 2022: $23.34 million | Fiscal year 2021: $32.34 million | Fiscal year 2020: $8.35 million | Fiscal year 2019: $9.68 million | Fiscal year 2018: -$3.45 million | Fiscal year 2017: -$11.01 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: